News
LONDON and NEW YORK, Sept. 19, 2019 /PRNewswire/ -- EBS, a leading provider of electronic trading platforms and technology services in foreign exc ...
Emergent BioSolutions Inc. EBS has acquired exclusive worldwide rights to Chimerix, Inc.’s CMRX smallpox oral antiviral product, Tembexa. The product is the first FDA-approved smallpox oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback